ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 395 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 395 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 395 | +146.9% | 0.00% | – |
| Q3 2021 | $1,000 | – | 160 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 160 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 160 | -47.4% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 304 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 304 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | +50.0% | 304 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |